Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 33,105 |
|
|||||
| News | - | ||||||
| Day High | 0.26089 | Low High |
|||||
| Day Low | 0.23 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Portage Biotech Inc | PRTG | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0031 | -1.28% | 0.24 | 17:31:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.25 | 0.23 | 0.26089 | 0.23 | 0.2431 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 104 | 33,105 | US$ 0.2453872 | US$ 8,124 | - | 0.1999 - 4.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:31:01 | formt | 100 | US$ 0.24 | USD |
Portage Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 4.75M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Portage Biotech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTG Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.25 | 0.2946 | 0.229 | 0.2471006 | 71,246 | -0.01 | -4.00% |
| 1 Month | 0.535 | 0.6399 | 0.1999 | 0.3092202 | 150,216 | -0.295 | -55.14% |
| 3 Months | 0.67 | 0.80 | 0.1999 | 0.4303716 | 100,980 | -0.43 | -64.18% |
| 6 Months | 1.97 | 2.17 | 0.1999 | 0.6641786 | 67,410 | -1.73 | -87.82% |
| 1 Year | 3.36 | 4.40 | 0.1999 | 1.15 | 43,236 | -3.12 | -92.86% |
| 3 Years | 28.27 | 44.9763 | 0.1999 | 8.46 | 36,481 | -28.03 | -99.15% |
| 5 Years | 37.50 | 44.9763 | 0.1999 | 8.91 | 35,051 | -37.26 | -99.36% |
Portage Biotech Description
| Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. |
